• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

红细胞分布宽度与急性冠状动脉事件全球注册风险评分联合预测行经皮冠状动脉介入治疗的急性冠状动脉综合征患者心血管事件的价值

Combined Value of Red Blood Cell Distribution Width and Global Registry of Acute Coronary Events Risk Score for Predicting Cardiovascular Events in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.

作者信息

Zhao Na, Mi Lan, Liu Xiaojun, Pan Shuo, Xu Jiaojiao, Xia Dongyu, Liu Zhongwei, Zhang Yong, Xiang Yu, Yuan Zuyi, Guan Gongchang, Wang Junkui

机构信息

Department of Cardiovascular Medicine, Shaanxi Province People's Hospital, Xi'an, Shaanxi, China.

Department of Medical Affairs, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China.

出版信息

PLoS One. 2015 Oct 15;10(10):e0140532. doi: 10.1371/journal.pone.0140532. eCollection 2015.

DOI:10.1371/journal.pone.0140532
PMID:26468876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4607415/
Abstract

Global Registry of Acute Coronary Events (GRACE) risk score and red blood cell distribution width (RDW) content can both independently predict major adverse cardiac events (MACEs) in patients with acute coronary syndrome (ACS). We investigated the combined predictive value of RDW and GRACE risk score for cardiovascular events in patients with ACS undergoing percutaneous coronary intervention (PCI) for the first time. We enrolled 480 ACS patients. During a median follow-up time of 37.2 months, 70 (14.58%) patients experienced MACEs. Patients were divided into tertiles according to the baseline RDW content (11.30-12.90, 13.00-13.50, 13.60-16.40). GRACE score was positively correlated with RDW content. Multivariate Cox analysis showed that both GRACE score and RDW content were independent predictors of MACEs (hazard ratio 1.039; 95% confidence interval [CI] 1.024-1.055; p < 0.001; 1.699; 1.294-2.232; p < 0.001; respectively). Furthermore, Kaplan-Meier analysis demonstrated that the risk of MACEs increased with increasing RDW content (p < 0.001). For GRACE score alone, the area under the receiver operating characteristic (ROC) curve for MACEs was 0.749 (95% CI: 0.707-0.787). The area under the ROC curve for MACEs increased to 0.805 (0.766-0.839, p = 0.034) after adding RDW content. The incremental predictive value of combining RDW content and GRACE risk score was significantly improved, also shown by the net reclassification improvement (NRI = 0.352, p < 0.001) and integrated discrimination improvement (IDI = 0.023, p = 0.002). Combining the predictive value of RDW and GRACE risk score yielded a more accurate predictive value for long-term cardiovascular events in ACS patients who underwent PCI as compared to each measure alone.

摘要

全球急性冠状动脉事件注册研究(GRACE)风险评分和红细胞分布宽度(RDW)均能独立预测急性冠状动脉综合征(ACS)患者的主要不良心脏事件(MACE)。我们研究了RDW和GRACE风险评分对首次接受经皮冠状动脉介入治疗(PCI)的ACS患者心血管事件的联合预测价值。我们纳入了480例ACS患者。在中位随访时间37.2个月期间,70例(14.58%)患者发生了MACE。根据基线RDW水平(11.30 - 12.90、13.00 - 13.50、13.60 - 16.40)将患者分为三分位数。GRACE评分与RDW水平呈正相关。多因素Cox分析显示,GRACE评分和RDW水平均为MACE的独立预测因素(风险比分别为1.039;95%置信区间[CI] 1.024 - 1.055;p < 0.001;1.699;1.294 - 2.232;p < 0.001)。此外,Kaplan - Meier分析表明,MACE风险随RDW水平升高而增加(p < 0.001)。仅对于GRACE评分,MACE的受试者工作特征(ROC)曲线下面积为0.749(95% CI:0.707 - 0.787)。加入RDW水平后,MACE的ROC曲线下面积增至0.805(0.766 - 0.839,p = 0.034)。联合RDW水平和GRACE风险评分的增量预测价值显著提高,净重新分类改善(NRI = 0.352,p < 0.001)和综合判别改善(IDI = 0.023,p = 0.002)也表明了这一点。与单独使用每种指标相比,联合RDW和GRACE风险评分的预测价值能更准确地预测接受PCI的ACS患者的长期心血管事件。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8710/4607415/545260fbad31/pone.0140532.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8710/4607415/615c086932d4/pone.0140532.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8710/4607415/545260fbad31/pone.0140532.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8710/4607415/615c086932d4/pone.0140532.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8710/4607415/545260fbad31/pone.0140532.g002.jpg

相似文献

1
Combined Value of Red Blood Cell Distribution Width and Global Registry of Acute Coronary Events Risk Score for Predicting Cardiovascular Events in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.红细胞分布宽度与急性冠状动脉事件全球注册风险评分联合预测行经皮冠状动脉介入治疗的急性冠状动脉综合征患者心血管事件的价值
PLoS One. 2015 Oct 15;10(10):e0140532. doi: 10.1371/journal.pone.0140532. eCollection 2015.
2
Adjustment of the GRACE score by HemoglobinA1c enables a more accurate prediction of long-term major adverse cardiac events in acute coronary syndrome without diabetes undergoing percutaneous coronary intervention.通过糖化血红蛋白调整GRACE评分能够更准确地预测接受经皮冠状动脉介入治疗的非糖尿病急性冠状动脉综合征患者的长期主要不良心脏事件。
Cardiovasc Diabetol. 2015 Aug 19;14:110. doi: 10.1186/s12933-015-0274-4.
3
Adjustment of the GRACE score by the triglyceride glucose index improves the prediction of clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.三酰甘油葡萄糖指数对 GRACE 评分的校正可改善行经皮冠状动脉介入治疗的急性冠状动脉综合征患者临床结局的预测。
Cardiovasc Diabetol. 2022 Aug 5;21(1):145. doi: 10.1186/s12933-022-01582-w.
4
Combination of the CYP2C19 metabolizer and the GRACE risk score better predicts the long-term major adverse cardiac events in acute coronary syndrome undergoing percutaneous coronary intervention.CYP2C19 代谢酶和 GRACE 风险评分的联合预测可更好地预测行经皮冠状动脉介入治疗的急性冠脉综合征患者的长期主要不良心脏事件。
Thromb Res. 2018 Oct;170:142-147. doi: 10.1016/j.thromres.2018.08.016. Epub 2018 Aug 24.
5
Improved predictive value of GRACE risk score combined with platelet reactivity for 1-year cardiovascular risk in patients with acute coronary syndrome who underwent coronary stent implantation.对于接受冠状动脉支架植入的急性冠状动脉综合征患者,GRACE风险评分联合血小板反应性对1年心血管风险的预测价值得到改善。
Platelets. 2016 Nov;27(7):650-657. doi: 10.3109/09537104.2016.1153618. Epub 2016 Apr 11.
6
Relationship of Red Cell Volume Distribution Width and N-Terminal Pro-Brain Natriuretic Peptide with Severity and Prognosis of Patients with Acute Coronary Syndrome Receiving Percutaneous Coronary Intervention.红细胞体积分布宽度和 N 末端脑利钠肽前体与接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者严重程度及预后的关系。
Clin Lab. 2020 Apr 1;66(4). doi: 10.7754/Clin.Lab.2019.190513.
7
Predictive impact on medium-term mortality of hematological parameters in Acute Coronary Syndromes: added value on top of GRACE risk score.急性冠脉综合征血液学参数对中期死亡率的预测影响:GRACE风险评分之外的附加价值
Eur Heart J Acute Cardiovasc Care. 2015 Apr;4(2):172-9. doi: 10.1177/2048872614547690. Epub 2014 Aug 13.
8
Combined effect of inflammation and malnutrition for long-term prognosis in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a cohort study.炎症和营养不良对行经皮冠状动脉介入治疗的急性冠状动脉综合征患者长期预后的联合影响:一项队列研究。
BMC Cardiovasc Disord. 2024 Jun 17;24(1):306. doi: 10.1186/s12872-024-03951-7.
9
The predictive value of the triglyceride glucose index combined with cystatin C for the prognosis of patients with acute coronary syndrome.三酰甘油葡萄糖指数联合胱抑素 C 对急性冠状动脉综合征患者预后的预测价值。
Front Endocrinol (Lausanne). 2024 Aug 14;15:1423227. doi: 10.3389/fendo.2024.1423227. eCollection 2024.
10
Roles of ST2, IL-33 and BNP in predicting major adverse cardiovascular events in acute myocardial infarction after percutaneous coronary intervention.ST2、IL-33 和 BNP 在预测经皮冠状动脉介入治疗后急性心肌梗死后主要不良心血管事件中的作用。
J Cell Mol Med. 2017 Nov;21(11):2677-2684. doi: 10.1111/jcmm.13183. Epub 2017 Jun 17.

引用本文的文献

1
Prognostic value of serum angiopoietin-like protein 2 in patients with acute coronary syndrome.血清血管生成素样蛋白2在急性冠状动脉综合征患者中的预后价值
BMC Cardiovasc Disord. 2024 Dec 19;24(1):709. doi: 10.1186/s12872-024-04391-z.
2
Prognostic potential of neutrophil-to-lymphocyte ratio, platelet to lymphocyte ratio, and monocyte to lymphocyte ratio in acute myocardial infarction patients combined with chronic obstructive pulmonary disease.中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值及单核细胞与淋巴细胞比值在急性心肌梗死合并慢性阻塞性肺疾病患者中的预后潜力
Front Cardiovasc Med. 2024 Jul 12;11:1401634. doi: 10.3389/fcvm.2024.1401634. eCollection 2024.
3

本文引用的文献

1
The effect of shift work on red blood cell distribution width.轮班工作对红细胞分布宽度的影响。
Physiol Behav. 2015 Apr 1;142:121-5. doi: 10.1016/j.physbeh.2015.01.020. Epub 2015 Jan 19.
2
Red cell distribution width is associated with incident myocardial infarction in a general population: the Tromsø Study.红细胞分布宽度与普通人群中心肌梗死的发生有关:特罗姆瑟研究。
J Am Heart Assoc. 2014 Aug 18;3(4):e001109. doi: 10.1161/JAHA.114.001109.
3
Predictive impact on medium-term mortality of hematological parameters in Acute Coronary Syndromes: added value on top of GRACE risk score.
Hemoglobin to red cell distribution width ratio as a prognostic marker for ischemic stroke after mechanical thrombectomy.
血红蛋白与红细胞分布宽度比值作为机械取栓术后缺血性卒中的预后标志物
Front Aging Neurosci. 2023 Nov 21;15:1259668. doi: 10.3389/fnagi.2023.1259668. eCollection 2023.
4
Relation of Red Cell Distribution Width to Glucose Metabolism and Adverse Long-Term Prognosis in Patients with Acute Coronary Syndrome.急性冠脉综合征患者红细胞分布宽度与糖代谢及不良长期预后的关系
Diabetes Metab Syndr Obes. 2023 Jan 11;16:61-70. doi: 10.2147/DMSO.S395923. eCollection 2023.
5
Prognostic Impact of Multiple Lymphocyte-Based Inflammatory Indices in Acute Coronary Syndrome Patients.多种基于淋巴细胞的炎症指标对急性冠状动脉综合征患者的预后影响
Front Cardiovasc Med. 2022 May 3;9:811790. doi: 10.3389/fcvm.2022.811790. eCollection 2022.
6
Prognostic Value of Plasma Cold-Inducible RNA-Binding Protein in Patients with Acute Coronary Syndrome.血浆冷诱导 RNA 结合蛋白对急性冠状动脉综合征患者的预后价值。
Dis Markers. 2022 Apr 27;2022:6119601. doi: 10.1155/2022/6119601. eCollection 2022.
7
Red Cell Distribution Width and Mortality in Patients Undergoing Percutaneous Coronary Intervention.接受经皮冠状动脉介入治疗患者的红细胞分布宽度与死亡率
Biomedicines. 2021 Dec 26;10(1):45. doi: 10.3390/biomedicines10010045.
8
Predictive value of neutrophil to lymphocyte ratio and red cell distribution width on death for ST segment elevation myocardial infarction.中性粒细胞与淋巴细胞比值和红细胞分布宽度对 ST 段抬高型心肌梗死患者死亡的预测价值。
Sci Rep. 2021 Jun 1;11(1):11506. doi: 10.1038/s41598-021-91082-w.
9
Prognostic value of red cell distribution width in patients undergoing percutaneous coronary intervention: a meta-analysis.红细胞分布宽度对行经皮冠状动脉介入治疗患者的预后价值:一项荟萃分析。
BMJ Open. 2020 Sep 10;10(9):e033378. doi: 10.1136/bmjopen-2019-033378.
10
The Effect of Red Cell Distribution Width Admission Value on the Outcome of Patients with First-ever ST-elevation Myocardial Infarction in Basrah.红细胞分布宽度入院值对巴士拉首次ST段抬高型心肌梗死患者预后的影响
Cureus. 2020 Mar 23;12(3):e7373. doi: 10.7759/cureus.7373.
急性冠脉综合征血液学参数对中期死亡率的预测影响:GRACE风险评分之外的附加价值
Eur Heart J Acute Cardiovasc Care. 2015 Apr;4(2):172-9. doi: 10.1177/2048872614547690. Epub 2014 Aug 13.
4
Red blood cell distribution width and long-term outcome in patients undergoing percutaneous coronary intervention in the drug-eluting stenting era: a two-year cohort study.药物洗脱支架时代接受经皮冠状动脉介入治疗患者的红细胞分布宽度与长期预后:一项为期两年的队列研究
PLoS One. 2014 Apr 10;9(4):e94887. doi: 10.1371/journal.pone.0094887. eCollection 2014.
5
Prognostic impact of admission blood glucose for all-cause mortality in patients with acute coronary syndromes: added value on top of GRACE risk score.急性冠脉综合征患者入院血糖对全因死亡率的预后影响:GRACE 风险评分之上的附加价值。
Eur Heart J Acute Cardiovasc Care. 2014 Sep;3(3):257-63. doi: 10.1177/2048872614528858. Epub 2014 Mar 31.
6
Combination of mean platelet volume and the GRACE risk score better predicts future cardiovascular events in patients with acute coronary syndrome.平均血小板体积与GRACE风险评分相结合能更好地预测急性冠状动脉综合征患者未来的心血管事件。
Platelets. 2014;25(6):447-51. doi: 10.3109/09537104.2013.830708. Epub 2013 Oct 8.
7
Relationship Between Red Cell Distribution Width and the GRACE Risk Score With In-Hospital Death in Patients With Acute Coronary Syndrome.急性冠状动脉综合征患者红细胞分布宽度与GRACE风险评分及院内死亡的关系
Clin Appl Thromb Hemost. 2014 Sep;20(6):577-82. doi: 10.1177/1076029613500707. Epub 2013 Aug 12.
8
Red cell distribution width is a predictor of mortality in patients undergoing percutaneous coronary intervention.红细胞分布宽度是经皮冠状动脉介入治疗患者死亡率的预测指标。
J Thromb Thrombolysis. 2013 Jan;35(1):57-64. doi: 10.1007/s11239-012-0767-x.
9
Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome.生长分化因子 15 对 GRACE 评分的调整可更准确地评估非 ST 段抬高型急性冠状动脉综合征的风险。
Eur Heart J. 2012 May;33(9):1095-104. doi: 10.1093/eurheartj/ehr444. Epub 2011 Dec 23.
10
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC).欧洲心脏病学会(ESC)非持续性ST段抬高型急性冠状动脉综合征患者管理指南:欧洲心脏病学会(ESC)非持续性ST段抬高型急性冠状动脉综合征(ACS)管理工作组。
Eur Heart J. 2011 Dec;32(23):2999-3054. doi: 10.1093/eurheartj/ehr236. Epub 2011 Aug 26.